HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Results of a phase I study to dose escalate using intensity modulated radiotherapy guided by combined PET/CT imaging with induction chemotherapy for patients with non-small cell lung cancer.

Abstract
Intensity modulated radiation therapy (IMRT) guided by PET/CT imaging with respiratory gating was employed to dose escalate in patients with non-small cell lung cancer (NSCLC), using accelerated fractionation with induction chemotherapies. One patient developed a grade 5 pneumonitis and the study was halted at 84 Gy in 35 fractions.
AuthorsCaroline L Holloway, Don Robinson, Brad Murray, John Amanie, Charles Butts, Michael Smylie, Karen Chu, A J McEwan, Ross Halperin, Wilson H Roa
JournalRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology (Radiother Oncol) Vol. 73 Issue 3 Pg. 285-7 (Dec 2004) ISSN: 0167-8140 [Print] Ireland
PMID15588872 (Publication Type: Clinical Trial, Clinical Trial, Phase I, Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Aged
  • Carcinoma, Non-Small-Cell Lung (pathology, radiotherapy)
  • Dose Fractionation, Radiation
  • Dose-Response Relationship, Radiation
  • Female
  • Humans
  • Lung Neoplasms (pathology, radiotherapy)
  • Male
  • Middle Aged
  • Positron-Emission Tomography
  • Radiation Pneumonitis
  • Tomography, X-Ray Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: